{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699993621246592.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s1470-2045(20)30494-0"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1470204520304940?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1470204520304940?httpAccept=text/plain"}}],"dc:title":[{"@value":"Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699993621246596","@type":"Researcher","foaf:name":[{"@value":"Paolo A Ascierto"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246464","@type":"Researcher","foaf:name":[{"@value":"Michele Del Vecchio"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246603","@type":"Researcher","foaf:name":[{"@value":"Mario Mandalá"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246608","@type":"Researcher","foaf:name":[{"@value":"Helen Gogas"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246597","@type":"Researcher","foaf:name":[{"@value":"Ana M Arance"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246598","@type":"Researcher","foaf:name":[{"@value":"Stephane Dalle"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246595","@type":"Researcher","foaf:name":[{"@value":"C Lance Cowey"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246343","@type":"Researcher","foaf:name":[{"@value":"Michael Schenker"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246338","@type":"Researcher","foaf:name":[{"@value":"Jean-Jacques Grob"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246604","@type":"Researcher","foaf:name":[{"@value":"Vanna Chiarion-Sileni"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246609","@type":"Researcher","foaf:name":[{"@value":"Iván Márquez-Rodas"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246341","@type":"Researcher","foaf:name":[{"@value":"Marcus O Butler"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246602","@type":"Researcher","foaf:name":[{"@value":"Michele Maio"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246594","@type":"Researcher","foaf:name":[{"@value":"Mark R Middleton"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246336","@type":"Researcher","foaf:name":[{"@value":"Luis de la Cruz-Merino"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246340","@type":"Researcher","foaf:name":[{"@value":"Petr Arenberger"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246337","@type":"Researcher","foaf:name":[{"@value":"Victoria Atkinson"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246605","@type":"Researcher","foaf:name":[{"@value":"Andrew Hill"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246592","@type":"Researcher","foaf:name":[{"@value":"Leslie A Fecher"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246342","@type":"Researcher","foaf:name":[{"@value":"Michael Millward"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246601","@type":"Researcher","foaf:name":[{"@value":"Nikhil I Khushalani"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246600","@type":"Researcher","foaf:name":[{"@value":"Paola Queirolo"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246607","@type":"Researcher","foaf:name":[{"@value":"Maurice Lobo"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246606","@type":"Researcher","foaf:name":[{"@value":"Veerle de Pril"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246339","@type":"Researcher","foaf:name":[{"@value":"John Loffredo"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246593","@type":"Researcher","foaf:name":[{"@value":"James Larkin"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993621246599","@type":"Researcher","foaf:name":[{"@value":"Jeffrey Weber"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"14702045"}],"prism:publicationName":[{"@value":"The Lancet Oncology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2020-11","prism:volume":"21","prism:number":"11","prism:startingPage":"1465","prism:endingPage":"1477"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1470204520304940?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1470204520304940?httpAccept=text/plain"}],"createdAt":"2020-09-19","modifiedAt":"2025-10-26","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050306506449699072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Treatment outcomes of the patient with sinonasal mucosal melanoma : the role of endoscopic resection and postoperative radiotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142505085952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017280655678592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282241951872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nail Apparatus Melanoma: Current Management and Future Perspectives"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643857401472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Retrospective analysis of adjuvant therapy using dabrafenib plus trametinib in Japanese patients with advanced melanoma: analysis of 36 cases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643858578688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gene therapy of prostate cancer using liposomes containing perforin expression vector driven by the promoter of prostate-specific antigen gene"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298754811195648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360579816408550400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360587979308484352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390573242454730624","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Case of preauricular primary malignant melanoma treated with preoperative dabrafenib/trametinib"},{"@language":"ja","@value":"術前にダブラフェニブ/トラメチニブを投与した耳前部原発悪性黒色腫の1例"}]},{"@id":"https://cir.nii.ac.jp/crid/1390587528328683648","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"免疫放射線治療後に遺残を疑った鼻副鼻腔粘膜悪性黒色腫に対する経鼻内視鏡手術"},{"@language":"en","@value":"Transnasal endoscopic surgery for sinonasal mucosal melanoma with suspected residual after immunoradiotherapy"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s1470-2045(20)30494-0"},{"@type":"CROSSREF","@value":"10.1016/j.ejca.2021.01.031_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.2340/actadv.v102.678_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.3390/jcm12062203_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.1097/cmr.0000000000000770_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.1038/s41598-021-03324-6_references_DOI_Uo3O1K3zod3Cj8SyXmqswX8STES"},{"@type":"CROSSREF","@value":"10.1097/cmr.0000000000000811_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.3390/ijms232415720_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.5981/jjhnc.51.281_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.5227/skincancer.36.203_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.1007/s10147-023-02368-0_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"},{"@type":"CROSSREF","@value":"10.3390/cancers16152755_references_DOI_ClmhWMfQ10WPmanLGscuxbKXiH2"}]}